Literature DB >> 6241767

Immunogenicity of HBV vaccine in healthy Chinese children.

L Y Hwang, R P Beasley, C E Stevens, W Szmuness.   

Abstract

The immunogenic response of healthy Chinese children to three different doses of hepatitis B virus (HBV) vaccine was compared. One hundred susceptible children received two doses of 10, 20 or 40 micrograms a month apart. A month following the first dose 33% of all the children had antibodies. The response rate rose to 78% a month later and 99% four months later. Ninety percent of the 100 children still had antibody at 12 months after vaccination was initiated. The response rate, antibody levels and persistence of antibody were directly related to the dose of vaccine and inversely to the age of children. No adverse reactions were observed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6241767     DOI: 10.1016/0264-410x(83)90005-1

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Immunogenicity of hepatitis B virus vaccine (Heptavax-B)--response of healthy adults.

Authors:  R P Beasley; L Y Hwang
Journal:  West J Med       Date:  1984-05

2.  Reduced response to hepatitis B virus vaccination in boys with steroid-sensitive nephrotic syndrome.

Authors:  A La Manna; C Polito; A C Foglia; A Di Toro; M R Cafaro; R Del Gado
Journal:  Pediatr Nephrol       Date:  1992-05       Impact factor: 3.714

Review 3.  Emerging hepatitis B virus infection in vaccinated populations: a rising concern?

Authors:  Tung-Hung Su; Pei-Jer Chen
Journal:  Emerg Microbes Infect       Date:  2012-09-19       Impact factor: 7.163

Review 4.  Prevalence of National Responsiveness to HBV Vaccine After 22 Years of Iranian Expanded Program on Immunization (EPI): A Systematic Review and Meta-Analysis Study.

Authors:  Reza Rezaee; Bahman Aghcheli; Vahdat Poortahmasebi; Mostafa Qorbani; Seyed Moayed Alavian; Seyed Mohammad Jazayeri
Journal:  Hepat Mon       Date:  2015-04-25       Impact factor: 0.660

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.